Dynavax Technologies Corp. (DVAX)
10.89
-0.08
(-0.73%)
USD |
NASDAQ |
Dec 09, 16:00
10.88
0.00 (0.00%)
After-Hours: 20:00
Dynavax Technologies EPS Diluted (Quarterly): 0.2063 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.316 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 26.93M |
| Revenue (Quarterly) | 94.88M |
| Total Expenses (Quarterly) | 67.95M |
| Enterprise Value | 920.17M |
| Gross Profit Margin (Quarterly) | 84.82% |
| Profit Margin (Quarterly) | 28.38% |
| Earnings Yield | -3.51% |
| Operating Earnings Yield | 0.69% |
| Normalized Earnings Yield | 0.719 |